Clinical Trials Browser

Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05305820 2024-03-21

PANO

Phase NA Unknown

36 enrolled

GastrointestinalGynecologic

Appendiceal Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Rectal Neoplasms

Clinical Trials

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

PANO

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

Pemb-HT

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

DCE-MRI

PITHAC

Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery

Family History Study on Cancer Risk

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

BENITA

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

STOPOVCA

ERASGYNBS002

SUROVA

Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

NEO

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

IMMUNOPARP

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

OPTI-DOSE

Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools

MIRRORS-RCTP

MITO-8

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer

Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

TOSCA

Factors Affecting the Prognosis of Early Ovarian Cancer

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

The Culture of Ovarian Cancer Organoids and Drug Screening

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

BEACON

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer

SELENIUM

Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.

Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer

Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Individualized Precision Treatment Based on Ovarian Cancer Organoid Model